These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 30102806)
1. Antiproliferative potential of miR-33a in laryngeal cancer Hep-2 cells via targeting PIM1. Karatas OF Head Neck; 2018 Nov; 40(11):2455-2461. PubMed ID: 30102806 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA LINC01003 suppresses the development of multiple myeloma by targeting miR-33a-5p/PIM1 axis. Wu L; Xia L; Chen X; Ruan M; Li L; Xia R Leuk Res; 2021 Jul; 106():106565. PubMed ID: 33865032 [TBL] [Abstract][Full Text] [Related]
3. The proto-oncogene Pim-1 is a target of miR-33a. Thomas M; Lange-Grünweller K; Weirauch U; Gutsch D; Aigner A; Grünweller A; Hartmann RK Oncogene; 2012 Feb; 31(7):918-28. PubMed ID: 21743487 [TBL] [Abstract][Full Text] [Related]
4. Biological function and mechanism of miR-33a in prostate cancer survival and metastasis: via downregulating Engrailed-2. Li Q; Lu S; Li X; Hou G; Yan L; Zhang W; Qiao B Clin Transl Oncol; 2017 May; 19(5):562-570. PubMed ID: 27921232 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of miR-129-5p affects laryngeal cancer cell proliferation, invasiveness, and migration by affecting STAT3 expression. Shen N; Huang X; Li J Tumour Biol; 2016 Feb; 37(2):1789-96. PubMed ID: 26318305 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-124-3p regulates cell proliferation, invasion, apoptosis, and bioenergetics by targeting PIM1 in astrocytoma. Deng D; Wang L; Chen Y; Li B; Xue L; Shao N; Wang Q; Xia X; Yang Y; Zhi F Cancer Sci; 2016 Jul; 107(7):899-907. PubMed ID: 27088547 [TBL] [Abstract][Full Text] [Related]
7. MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA. Du M; Zhang Y; Mao Y; Mou J; Zhao J; Xue Q; Wang D; Huang J; Gao S; Gao Y Biochem Biophys Res Commun; 2017 Jan; 482(4):582-589. PubMed ID: 27856248 [TBL] [Abstract][Full Text] [Related]
8. miR-486 inhibited osteosarcoma cells invasion and epithelial-mesenchymal transition by targeting PIM1. Liu Y; Zhang J; Xing C; Wei S; Guo N; Wang Y Cancer Biomark; 2018; 23(2):269-277. PubMed ID: 30103304 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-4497 functions as a tumor suppressor in laryngeal squamous cell carcinoma via negatively modulation the GBX2. Chen X; Zhang L; Tang S Auris Nasus Larynx; 2019 Feb; 46(1):106-113. PubMed ID: 29843929 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Ibrahim AF; Weirauch U; Thomas M; Grünweller A; Hartmann RK; Aigner A Cancer Res; 2011 Aug; 71(15):5214-24. PubMed ID: 21690566 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA CCAT1/miR-218/ZFX axis modulates the progression of laryngeal squamous cell cancer. Zhang Y; Hu H Tumour Biol; 2017 Jun; 39(6):1010428317699417. PubMed ID: 28631575 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-379 inhibits laryngeal carcinoma cell proliferation and invasion through directly targeting TCF-4. Wei JL; Zhang L; Zhao ZM; Zhao YZ; Fu Q; Yang Y Kaohsiung J Med Sci; 2019 Dec; 35(12):731-738. PubMed ID: 31436384 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1. Ye J; Li L; Feng P; Wan J; Li J Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728 [TBL] [Abstract][Full Text] [Related]
14. Knockdown of DGCR5 enhances the radiosensitivity of human laryngeal carcinoma cells via inducing miR-195. Tang T; Shan G; Zeng F J Cell Physiol; 2019 Aug; 234(8):12918-12925. PubMed ID: 30549038 [TBL] [Abstract][Full Text] [Related]
15. miRNA-370 acts as a tumor suppressor via the downregulation of PIM1 in hepatocellular carcinoma. Pan XP; Wang HX; Tong DM; Li Y; Huang LH; Wang C Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1254-1263. PubMed ID: 28387905 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinoma. Han SY; Han HB; Tian XY; Sun H; Xue D; Zhao C; Jiang ST; He XR; Zheng WX; Wang J; Pang LN; Li XH; Li PP Oncotarget; 2016 Jul; 7(27):42461-42473. PubMed ID: 27285759 [TBL] [Abstract][Full Text] [Related]
17. [Growth inhibitory effect of microRNA-519b-3p on larynx squamous Hep-2 cells]. Shen Z; Zhan G; Deng H; Kang C; Guo J Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Feb; 49(2):151-6. PubMed ID: 24742516 [TBL] [Abstract][Full Text] [Related]
18. MiR-503 enhances the radiosensitivity of laryngeal carcinoma cells via the inhibition of WEE1. Ma H; Lian R; Wu Z; Li X; Yu W; Shang Y; Guo X Tumour Biol; 2017 Oct; 39(10):1010428317706224. PubMed ID: 29019284 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. Kuo PL; Liao SH; Hung JY; Huang MS; Hsu YL Biochim Biophys Acta; 2013 Jun; 1830(6):3756-66. PubMed ID: 23458685 [TBL] [Abstract][Full Text] [Related]
20. Role of miR-145 in human laryngeal squamous cell carcinoma. Karatas OF; Yuceturk B; Suer I; Yilmaz M; Cansiz H; Solak M; Ittmann M; Ozen M Head Neck; 2016 Feb; 38(2):260-6. PubMed ID: 26083661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]